Insider Trading Activity HealthEquity Inc. (NASDAQ:HQY) – VP Sold 10,000 shares of Stock

0

Insider Trading Activity For HealthEquity Inc. (NASDAQ:HQY)

Darcy G Mott , VP of HealthEquity Inc. (NASDAQ:HQY) reportedly Sold 10,000 shares of the company’s stock at an average price of 40.12 for a total transaction amount of $401,200.00 SEC Form

Insider Trading History For HealthEquity Inc. (NASDAQ:HQY)

  • On 8/5/2014 Frode Jensen, VP, bought 3,000 with an average share price of $14.00 per share and the total transaction amounting to $42,000.00.
  • On 8/5/2014 Frank Medici, Director, bought 12,500 with an average share price of $14.00 per share and the total transaction amounting to $175,000.00.
  • On 8/5/2014 Darcy G Mott, CFO, bought 2,000 with an average share price of $14.00 per share and the total transaction amounting to $28,000.00.
  • On 4/28/2015 Ashley Dreier, VP, sold 3,125 with an average share price of $27.00 per share and the total transaction amounting to $84,375.00.
  • On 5/11/2015 Jon Kessler, CEO, sold 100,000 with an average share price of $24.86 per share and the total transaction amounting to $2,486,000.00.
  • On 5/11/2015 Frank Medici, Director, sold 1,125,000 with an average share price of $24.86 per share and the total transaction amounting to $27,967,500.00.
  • On 5/11/2015 Darcy G Mott, CFO, sold 120,000 with an average share price of $24.86 per share and the total transaction amounting to $2,983,200.00.
  • Analyst Ratings For HealthEquity Inc. (NASDAQ:HQY)
    These are 1 Hold Rating, 8 Buy RatingsThe current consensus rating for HealthEquity Inc. (NASDAQ:HQY) is Buy (Score: 2.89) with a consensus target price of $38.25 , a potential (5.63% downside)

    Analyst Ratings History For HealthEquity Inc. (NASDAQ:HQY)

    • On 3/23/2016 Avondale Partners Boost Price Target of rating Market Outperform with a price target of $25.00 to $27.00
    • On 6/8/2016 Leerink Swann Reiterated Rating Outperform with a price target of $30.00 to $33.00
    • On 6/22/2016 Wells Fargo & Co. Reiterated Rating Buy
    • On 9/7/2016 Robert W. Baird Boost Price Target of rating Neutral with a price target of $31.00 to $35.00
    • On 9/8/2016 Barrington Research Boost Price Target of rating Outperform with a price target of $34.00 to $38.00
    • On 9/8/2016 SunTrust Banks Inc. Reiterated Rating Buy
    • On 9/12/2016 Raymond James Financial Inc. Boost Price Target of rating Outperform with a price target of $32.00 to $40.00

    About HealthEquity Inc. (NASDAQ:HQY)
    HealthEquity, Inc. provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. Its platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings. Its products and services include healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements and healthcare incentives. Its ecosystem primarily consists of HSA.

    Recent Trading Activity for HealthEquity Inc. (NASDAQ:HQY)
    Shares of HealthEquity Inc. closed the previous trading session at 40.53 0.00 0.00% with 240,387 shares trading hands.